UnicoCell Biomed Statistics

Total Valuation

TPE:6794 has a market cap or net worth of TWD 4.98 billion. The enterprise value is 4.29 billion.

Market Cap	4.98B
Enterprise Value	4.29B

Important Dates

The last earnings date was Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

TPE:6794 has 60.68 million shares outstanding. The number of shares has increased by 5.90% in one year.

Current Share Class	60.68M
Shares Outstanding	60.68M
Shares Change (YoY)	+5.90%
Shares Change (QoQ)	+3.30%
Owned by Insiders (%)	15.91%
Owned by Institutions (%)	n/a
Float	33.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	165.29
PB Ratio	5.75
P/TBV Ratio	5.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-37.32
EV / Sales	142.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-44.27

Financial Position

The company has a current ratio of 37.98, with a Debt / Equity ratio of 0.07.

Current Ratio	37.98
Quick Ratio	36.62
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.64
Interest Coverage	-97.30

Financial Efficiency

Return on equity (ROE) is -14.82% and return on invested capital (ROIC) is -9.69%.

Return on Equity (ROE)	-14.82%
Return on Assets (ROA)	-9.45%
Return on Invested Capital (ROIC)	-9.69%
Return on Capital Employed (ROCE)	-14.08%
Weighted Average Cost of Capital (WACC)	2.19%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.03
Inventory Turnover	1.23

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.57% in the last 52 weeks. The beta is -0.37, so TPE:6794's price volatility has been lower than the market average.

Beta (5Y)	-0.37
52-Week Price Change	+11.57%
50-Day Moving Average	86.87
200-Day Moving Average	75.36
Relative Strength Index (RSI)	38.33
Average Volume (20 Days)	86,204

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:6794 had revenue of TWD 30.10 million and -114.84 million in losses. Loss per share was -1.89.

Revenue	30.10M
Gross Profit	18.98M
Operating Income	-130.28M
Pretax Income	-114.84M
Net Income	-114.84M
EBITDA	-109.73M
EBIT	-130.28M
Loss Per Share	-1.89

Full Income Statement

Balance Sheet

The company has 752.02 million in cash and 62.02 million in debt, giving a net cash position of 690.00 million or 11.37 per share.

Cash & Cash Equivalents	752.02M
Total Debt	62.02M
Net Cash	690.00M
Net Cash Per Share	11.37
Equity (Book Value)	865.44M
Book Value Per Share	13.81
Working Capital	766.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -91.31 million and capital expenditures -5.50 million, giving a free cash flow of -96.81 million.

Operating Cash Flow	-91.31M
Capital Expenditures	-5.50M
Free Cash Flow	-96.81M
FCF Per Share	-1.60

Full Cash Flow Statement

Margins

Gross Margin	63.04%
Operating Margin	-432.77%
Pretax Margin	-381.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPE:6794 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.90%
Shareholder Yield	-5.90%
Earnings Yield	-2.31%
FCF Yield	-1.95%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2